IMMUNIC, INC. — Director's Dealing 2018

Sep 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2018-09-13

Reporting Person: Hasnain Faheem (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-13	Common Stock	S	59200	$0.4377	Disposed	122743	Direct
2018-09-13	Common Stock	S	118243	$0.4378	Disposed	4500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500	Indirect